View Older Stories View More Recent Stories

Dec 2, 2024 02:46PM Lilly Products Show Strength Heading Into the Holiday

Nov 26, 2024 07:11AM Amgen (AMGN) Falls 8% Following Obesity Data, Rivals Lilly (LLY), Novo Nordisk (NVO) Gain 4%

Nov 26, 2024 06:35AM Deutsche Bank Reiterates Buy Rating on Novo Nordisk (NOVOB:DC) (NVO)

Nov 26, 2024 06:09AM Eli Lilly & Co. (LLY) and Novo Nordisk (NVO) gain on Biden's GLP-1 proposal

Nov 26, 2024 05:53AM Novo Nordisk (NVO) call put ratio 2.9 calls to 1 put into share price up before the bell

Nov 22, 2024 02:06PM BMO Capital Reiterates Outperform Rating on Novo Nordisk (NVO)

Nov 22, 2024 04:55AM Barclays Reiterates Overweight Rating on Novo Nordisk (NOVOB:DC) (NVO) into 'the most eagerly awaited clinical catalyst for our space of this year'

Nov 18, 2024 02:10PM BMO Capital Reiterates Outperform Rating on Eli Lilly (LLY)

Nov 13, 2024 07:34AM Novo Nordisk added to Citi's Europe 1 list of top ideas

Nov 11, 2024 02:21AM JPMorgan Reiterates Overweight Rating on Novo Nordisk (NOVOB:DC) (NVO)

Nov 7, 2024 10:20AM Novo Nordisk (NOVOB:DC) (NVO) PT Lowered to DKK1,000 at Deutsche Bank

Nov 6, 2024 03:50AM Novo Nordisk (NVO) Reports Q3 EPS of DKK6.12; offers outlook

Nov 5, 2024 10:15AM Novo Nordisk (NVO) call put ratio 1.6 calls to 1 put as share price down 1%

Nov 5, 2024 06:05AM Novo Nordisk (NVO) call put ratio 2.2 calls to 1 put into quarter results

Nov 4, 2024 11:03AM Novo Nordisk (NVO) call put ratio 1.4 calls to 1 put into quarter results

Nov 1, 2024 08:22AM Madrigal Pharma (MDGL) Falls 9.3% Following Data from Novo Nordisk (NVO)

Nov 1, 2024 08:21AM Novo Nordisk (NVO) announces Semaglutide 2.4 mg demonstrates superior improvement in both liver fibrosis and MASH resolution in the ESSENCE trial

Oct 30, 2024 08:33AM Tiziana Life Sciences (TLSA) Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study

Oct 28, 2024 07:52AM Erste Group Downgrades Novo Nordisk (NOVOB:DC) (NVO) to Hold, 'strong growth'

Oct 8, 2024 02:25PM Obesity Drug Coverage Could Boost Spending By $35B Through 2034: CBO

Oct 7, 2024 09:24AM TD Cowen Reiterates Buy Rating on Novo Nordisk (NVO)

Oct 3, 2024 02:39AM UBS Reiterates Neutral Rating on Novo Nordisk (NOVOB:DC) (NVO)

Oct 2, 2024 06:36AM Novo Nordisk (NOVOB:DC) (NVO) PT Lowered to DKK1,075 at BofA Securities

Oct 2, 2024 05:42AM Novo Nordisk (NVO) PT Lowered to $159.50 at BofA Securities

Sep 27, 2024 08:00AM Buy any potential weakness in this big pharma stock: JPMorgan

Sep 27, 2024 07:56AM Citi Reiterates Buy Rating on Novo Nordisk (NOVOB:DC) (NVO)

Sep 26, 2024 06:34AM Berenberg Reiterates Hold Rating on Novo Nordisk (NOVOB:DC) (NVO)

Sep 24, 2024 04:48AM Novo Nordisk (NVO) call put ratio 1 call to 1.3 puts into Novo CEO Lars Jørgensen will testify at HELP hearing

Sep 23, 2024 07:35AM BMO Capital Reiterates Outperform Rating on Novo Nordisk (NVO)

Sep 20, 2024 11:01AM Novo Nordisk (NVO) call put ratio 1.7 calls to 1 put amid share price down 5.9%

Sep 20, 2024 10:12AM TD Cowen Reiterates Buy Rating on Novo Nordisk (NVO) Following Monlunabant Obesity Update

Sep 20, 2024 09:56AM Monlunabant early obesity data not a key driver for Novo Nordisk (NVO) - BMO

Sep 20, 2024 09:31AM Novo Nordisk shares fall after Monlunabant phase 2a trial results; Viking jumps

Sep 20, 2024 09:00AM Corbus Pharma (CRBP) Quickly Falls 52%

Sep 20, 2024 09:00AM Corbus Pharma (CRBP) sink over 55% on Novo Nordisk (NVO) data

Sep 20, 2024 08:57AM Novo Nordisk (NVO) Declines 2.5% After Headline Results from Phase 2a Clinical trial with Monlunabant

Sep 20, 2024 08:49AM Novo Nordisk (NVO): Monlunabant phase 2a trial in obesity successfully completed

Sep 19, 2024 03:13PM Novo Nordisk (NVO): Wegovy recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function

Sep 19, 2024 05:54AM Novo Nordisk (NVO) option IV flat on low option volume

Sep 11, 2024 12:40PM Novo Nordisk (NVO) Shares Gain 4%, See Volume Buying Pressure

Sep 11, 2024 12:08PM Cantor Fitzgerald on Novo Nordisk (NVO): 'These data compare favorably to other orals in development'

Sep 11, 2024 12:06PM Novo Nordisk (NVO) ADRs Continue Gains, Up ~3.5% Now

Sep 11, 2024 11:50AM Roche Says Obesity Pill’s Side Effects Blunted by Gradual Dosing - Bloomberg

Sep 11, 2024 08:32AM BMO Capital on Novo Nordisk (NVO): 'given that Amycretin is a peptide we would like to hear more from Novo on manufacturing, a potential point of differentiation for the small molecule assets'

Sep 11, 2024 07:27AM Novo Nordisk (NVO) gains after oral amycretin presentation

Sep 9, 2024 07:00PM Piper Sandler answers: who has the best obesity drug of all?

Sep 5, 2024 02:31AM Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK1,050 at JPMorgan

Aug 27, 2024 10:06AM Novo Nordisk (NVO) call put ratio 1 call to 3.6 puts after Eli Lilly & Co. (LLY) launches single-dose vials of Zepbound

Aug 20, 2024 07:59AM Lilly’s Zepbound cuts risk of diabetes by 94% in obese patients, shares gain

Aug 12, 2024 08:14AM Deutsche Bank upgrades Eli Lilly stock to Buy, sees 15% upside potential

View More Recent Stories View Older Stories